Skip to main content
SemaglutideInjectionsCA

Wegovy in Canada

What wegovy costs in Canada, which licensed clinics prescribe it, and what Health Canada has actually authorised it for.

Updated: July 28, 2026

Editorial testing in progress

We have not finished verifying Canadian wegovy providers against real provincial availability, and we would rather publish nothing than publish rankings we have not checked. In the meantime, our published categories below are live.

SemaglutideSemaglutide for Weight Loss

Prescription notice

GLP-1 medications, finasteride, NAD+ injections and the other treatments compared on this site are prescription-only in Canada. A prescription is issued only when a clinician licensed in your province determines it is clinically appropriate for you. Approval is never guaranteed.

Explore More Treatments

Best Semaglutide in Canada
Semaglutide in Canada — generic, Ozempic and Wegovy — from licensed Canadian telehealth clinics, compared on all-in monthly cost.
Best Semaglutide for Weight Loss in Canada
Semaglutide weight loss programs from licensed Canadian telehealth clinics, compared on all-in monthly cost in CAD.

Wegovy Availability by Province

Telehealth is regulated provincially in Canada. Confirm your province is served before paying a consultation fee.

OntarioBritish ColumbiaAlbertaQuebecManitobaSaskatchewanNova ScotiaNew BrunswickPrince Edward IslandNewfoundland and Labrador

Frequently Asked Questions

Both are semaglutide from the same manufacturer. Wegovy is authorised in Canada for weight management and titrates to 2.4 mg; Ozempic is authorised for type 2 diabetes at doses up to 2.0 mg. Same molecule — different authorised indication, different maximum dose, different device.

References and further reading

  1. Health Canada, Wegovy Regulatory Decision Summary (Health Canada). Canadian approval of semaglutide 2.4 mg for chronic weight management.
  2. NEJM, STEP 1 trial of semaglutide for weight loss (New England Journal of Medicine). Landmark trial evidence for weight-loss effectiveness.
  3. Obesity Canada and CMAJ, 2025 pharmacotherapy guideline (CMAJ / Obesity Canada). Canadian obesity guideline on long-term weight-management medicine.

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.